schliessen

Filtern

 

Bibliotheken

Factors Associated with Response to Acetylcholinesterase Inhibition in Dementia: A Cohort Study from a Secondary Mental Health Care Case Register in London

Background Acetylcholinesterase inhibitors (AChEIs) are widely used to delay cognitive decline in Alzheimer's disease. Observational studies in routine clinical practice have shown cognitive improvement in some groups of patients receiving these agents but longitudinal trajectories before and after... Full description

Journal Title: PLoS ONE 2014, Vol.9(11)
Main Author: Perera, Gayan
Other Authors: Khondoker, Mizanur , Broadbent, Matthew , Breen, Gerome , Stewart, Robert
Format: Electronic Article Electronic Article
Language:
Subjects:
ID: E-ISSN: 1932-6203 ; DOI: 10.1371/journal.pone.0109484 ; PMCID: 4239015 ; PMID: 25411838
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: pubmed_central4239015
title: Factors Associated with Response to Acetylcholinesterase Inhibition in Dementia: A Cohort Study from a Secondary Mental Health Care Case Register in London
format: Article
creator:
  • Perera, Gayan
  • Khondoker, Mizanur
  • Broadbent, Matthew
  • Breen, Gerome
  • Stewart, Robert
subjects:
  • Research Article
  • Medicine And Health Sciences
  • Research And Analysis Methods
ispartof: PLoS ONE, 2014, Vol.9(11)
description: Background Acetylcholinesterase inhibitors (AChEIs) are widely used to delay cognitive decline in Alzheimer's disease. Observational studies in routine clinical practice have shown cognitive improvement in some groups of patients receiving these agents but longitudinal trajectories before and after AChEI initiation have not previously been considered. Objectives To compare trajectories of cognitive function before and after AChEI initiation and investigate predictors of these differences. Method A retrospective longitudinal study was constructed using data from 2460 patients who received AChEIs and who had routine data on cognitive function (Mini-Mental State Examination; MMSE) before and after AChEI initiation. Longitudinal MMSE change was modelled using three-piece linear mixed models with the following segments: 0–12 months prior to AChEI initiation, 0–6 months and 6–36 months after initiation. Results MMSE decline was reversed (in that the slope was improved by an average 4.2 units per year, 95% CI 3.5–4.8) during the 6-month period following AChEI initiation compared with the slope in the one year period before AChEI initiation. The slope in the period from 6–36 months following AChEI initiation returned to the pre-initiation downward trajectory. The differences in slopes in the 1 year period prior to AChEI initiation and in the 6 months after initiation were smaller among those with higher MMSE scores at the time of AChEI initiation, among those who received a vascular dementia diagnosis at any point, and among those receiving antipsychotic agents. Conclusion In this naturalistic observational study, changes in cognitive trajectories around AChEI initiation were similar to those reported in randomised controlled trials. The magnitude of the difference in slopes between the 1 year period prior to AChEI initiation and the 6 month period after AChEI initiation was related to level of cognitive function at treatment initiation, vascular comorbidity and antipsychotic use.
language:
source:
identifier: E-ISSN: 1932-6203 ; DOI: 10.1371/journal.pone.0109484 ; PMCID: 4239015 ; PMID: 25411838
fulltext: fulltext
issn:
  • 1932-6203
  • 19326203
url: Link


@attributes
ID108021502
RANK0.07
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
LOCALfalse
PrimoNMBib
record
control
sourcerecordid4239015
sourceidpubmed_central
recordidTN_pubmed_central4239015
sourceformatXML
sourcesystemPC
pqid1626535089
galeid418139487
display
typearticle
titleFactors Associated with Response to Acetylcholinesterase Inhibition in Dementia: A Cohort Study from a Secondary Mental Health Care Case Register in London
creatorPerera, Gayan ; Khondoker, Mizanur ; Broadbent, Matthew ; Breen, Gerome ; Stewart, Robert
contributorSkoulakis, Efthimios M. C. (editor)
ispartofPLoS ONE, 2014, Vol.9(11)
identifier
subjectResearch Article ; Medicine And Health Sciences ; Research And Analysis Methods
descriptionBackground Acetylcholinesterase inhibitors (AChEIs) are widely used to delay cognitive decline in Alzheimer's disease. Observational studies in routine clinical practice have shown cognitive improvement in some groups of patients receiving these agents but longitudinal trajectories before and after AChEI initiation have not previously been considered. Objectives To compare trajectories of cognitive function before and after AChEI initiation and investigate predictors of these differences. Method A retrospective longitudinal study was constructed using data from 2460 patients who received AChEIs and who had routine data on cognitive function (Mini-Mental State Examination; MMSE) before and after AChEI initiation. Longitudinal MMSE change was modelled using three-piece linear mixed models with the following segments: 0–12 months prior to AChEI initiation, 0–6 months and 6–36 months after initiation. Results MMSE decline was reversed (in that the slope was improved by an average 4.2 units per year, 95% CI 3.5–4.8) during the 6-month period following AChEI initiation compared with the slope in the one year period before AChEI initiation. The slope in the period from 6–36 months following AChEI initiation returned to the pre-initiation downward trajectory. The differences in slopes in the 1 year period prior to AChEI initiation and in the 6 months after initiation were smaller among those with higher MMSE scores at the time of AChEI initiation, among those who received a vascular dementia diagnosis at any point, and among those receiving antipsychotic agents. Conclusion In this naturalistic observational study, changes in cognitive trajectories around AChEI initiation were similar to those reported in randomised controlled trials. The magnitude of the difference in slopes between the 1 year period prior to AChEI initiation and the 6 month period after AChEI initiation was related to level of cognitive function at treatment initiation, vascular comorbidity and antipsychotic use.
source
version7
lds50peer_reviewed
links
openurl$$Topenurl_article
openurlfulltext$$Topenurlfull_article
search
creatorcontrib
0Perera, Gayan
1Khondoker, Mizanur
2Broadbent, Matthew
3Breen, Gerome
4Stewart, Robert
5Skoulakis, Efthimios M. C
titleFactors Associated with Response to Acetylcholinesterase Inhibition in Dementia: A Cohort Study from a Secondary Mental Health Care Case Register in London
descriptionBackground Acetylcholinesterase inhibitors (AChEIs) are widely used to delay cognitive decline in Alzheimer's disease. Observational studies in routine clinical practice have shown cognitive improvement in some groups of patients receiving these agents but longitudinal trajectories before and after AChEI initiation have not previously been considered. Objectives To compare trajectories of cognitive function before and after AChEI initiation and investigate predictors of these differences. Method A retrospective longitudinal study was constructed using data from 2460 patients who received AChEIs and who had routine data on cognitive function (Mini-Mental State Examination; MMSE) before and after AChEI initiation. Longitudinal MMSE change was modelled using three-piece linear mixed models with the following segments: 0–12 months prior to AChEI initiation, 0–6 months and 6–36 months after initiation. Results MMSE decline was reversed (in that the slope was improved by an average 4.2 units per year, 95% CI 3.5–4.8) during the 6-month period following AChEI initiation compared with the slope in the one year period before AChEI initiation. The slope in the period from 6–36 months following AChEI initiation returned to the pre-initiation downward trajectory. The differences in slopes in the 1 year period prior to AChEI initiation and in the 6 months after initiation were smaller among those with higher MMSE scores at the time of AChEI initiation, among those who received a vascular dementia diagnosis at any point, and among those receiving antipsychotic agents. Conclusion In this naturalistic observational study, changes in cognitive trajectories around AChEI initiation were similar to those reported in randomised controlled trials. The magnitude of the difference in slopes between the 1 year period prior to AChEI initiation and the 6 month period after AChEI initiation was related to level of cognitive function at treatment initiation, vascular comorbidity and antipsychotic use.
subject
0Research Article
1Medicine and health sciences
2Research and Analysis Methods
general
025411838
14239015
210.1371/journal.pone.0109484
3PMC (PubMed Central)
sourceidpubmed_central
recordidpubmed_central4239015
issn
01932-6203
119326203
rsrctypearticle
creationdate2014
addtitlePLoS ONE
searchscopepubmed_central
scopepubmed_central
lsr30VSR-Enriched:[pqid, pages, galeid]
sort
titleFactors Associated with Response to Acetylcholinesterase Inhibition in Dementia: A Cohort Study from a Secondary Mental Health Care Case Register in London
authorPerera, Gayan ; Khondoker, Mizanur ; Broadbent, Matthew ; Breen, Gerome ; Stewart, Robert
creationdate20141120
facets
frbrgroupid1426124687798319830
frbrtype5
newrecords20180411
creationdate2014
topic
0Research Article
1Medicine And Health Sciences
2Research And Analysis Methods
collectionPMC (PubMed Central)
prefilterarticles
rsrctypearticles
creatorcontrib
0Perera, Gayan
1Khondoker, Mizanur
2Broadbent, Matthew
3Breen, Gerome
4Stewart, Robert
5Skoulakis, Efthimios M. C.
jtitlePlos One
toplevelpeer_reviewed
delivery
delcategoryRemote Search Resource
fulltextfulltext
addata
aulast
0Perera
1Khondoker
2Broadbent
3Breen
4Stewart
5Skoulakis
aufirst
0Gayan
1Mizanur
2Matthew
3Gerome
4Robert
5Efthimios M. C.
au
0Perera, Gayan
1Khondoker, Mizanur
2Broadbent, Matthew
3Breen, Gerome
4Stewart, Robert
5Skoulakis, Efthimios M. C.
atitleFactors Associated with Response to Acetylcholinesterase Inhibition in Dementia: A Cohort Study from a Secondary Mental Health Care Case Register in London
jtitlePLoS ONE
risdate20141120
volume9
issue11
eissn1932-6203
formatjournal
genrearticle
ristypeJOUR
abstractBackground Acetylcholinesterase inhibitors (AChEIs) are widely used to delay cognitive decline in Alzheimer's disease. Observational studies in routine clinical practice have shown cognitive improvement in some groups of patients receiving these agents but longitudinal trajectories before and after AChEI initiation have not previously been considered. Objectives To compare trajectories of cognitive function before and after AChEI initiation and investigate predictors of these differences. Method A retrospective longitudinal study was constructed using data from 2460 patients who received AChEIs and who had routine data on cognitive function (Mini-Mental State Examination; MMSE) before and after AChEI initiation. Longitudinal MMSE change was modelled using three-piece linear mixed models with the following segments: 0–12 months prior to AChEI initiation, 0–6 months and 6–36 months after initiation. Results MMSE decline was reversed (in that the slope was improved by an average 4.2 units per year, 95% CI 3.5–4.8) during the 6-month period following AChEI initiation compared with the slope in the one year period before AChEI initiation. The slope in the period from 6–36 months following AChEI initiation returned to the pre-initiation downward trajectory. The differences in slopes in the 1 year period prior to AChEI initiation and in the 6 months after initiation were smaller among those with higher MMSE scores at the time of AChEI initiation, among those who received a vascular dementia diagnosis at any point, and among those receiving antipsychotic agents. Conclusion In this naturalistic observational study, changes in cognitive trajectories around AChEI initiation were similar to those reported in randomised controlled trials. The magnitude of the difference in slopes between the 1 year period prior to AChEI initiation and the 6 month period after AChEI initiation was related to level of cognitive function at treatment initiation, vascular comorbidity and antipsychotic use.
pubPublic Library of Science
doi10.1371/journal.pone.0109484
pmid25411838
pagese109484
oafree_for_read
date2014-11-20